| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5P2 NPY2R OR5V1 FPR2 OR4E1 MC3R GPR37L1 OR1F12P OR5K4 GPR87 GRM5 GRM7 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 BRS3 OR1Q1 OR52E1 OR52E5 OR6Y1 GPRC5D CCR7 OR10G8 OR6C6 GPR132 | 7.38e-14 | 884 | 114 | 28 | GO:0004930 |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRM7 RYR1 RYR2 HMCN1 PCDHGA12 ATP2A1 PCDHGA8 | 8.28e-14 | 749 | 114 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5P2 ERBB2 NPY2R OR5V1 FPR2 OR4E1 MC3R GPR37L1 OR1F12P OR5K4 GPR87 TLR6 GRM5 GRM7 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 PTPRD BRS3 OR1Q1 OR52E1 OR52E5 OR6Y1 GPRC5D CCR7 OR10G8 OR6C6 GPR132 | 1.33e-11 | 1353 | 114 | 31 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 2.39e-08 | 431 | 114 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.15e-04 | 133 | 114 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.53e-04 | 140 | 114 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | sucrose transmembrane transporter activity | 1.92e-04 | 4 | 114 | 2 | GO:0008515 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 1.92e-04 | 4 | 114 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | sucrose:proton symporter activity | 1.92e-04 | 4 | 114 | 2 | GO:0008506 | |
| GeneOntologyMolecularFunction | oligosaccharide transmembrane transporter activity | 1.92e-04 | 4 | 114 | 2 | GO:0015157 | |
| GeneOntologyMolecularFunction | disaccharide transmembrane transporter activity | 1.92e-04 | 4 | 114 | 2 | GO:0015154 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.92e-04 | 4 | 114 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | sucrose:monoatomic cation symporter activity | 1.92e-04 | 4 | 114 | 2 | GO:0009669 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 3.19e-04 | 5 | 114 | 2 | GO:0000064 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 GRM7 RYR1 RYR2 KCNH4 SLC45A4 SLC6A1 SLC4A10 NIPA2 SLC45A1 ATP2A1 ATP2A3 MFSD5 | 3.90e-04 | 758 | 114 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.77e-04 | 6 | 114 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 8.85e-04 | 8 | 114 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | GRM7 RYR1 RYR2 KCNH4 SLC45A4 SLC6A1 SLC4A10 NIPA2 SLC45A1 ATP2A1 ATP2A3 | 9.25e-04 | 627 | 114 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | transporter activity | ABCC1 ATP9B GRM7 RYR1 RYR2 KCNH4 SLC45A4 SLCO1B7 SLC6A1 SLC7A1 SLC7A3 SLC4A10 NIPA2 SLC45A1 ATP2A1 ATP2A3 MFSD5 | 1.01e-03 | 1289 | 114 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 GRM7 RYR1 RYR2 KCNH4 SLC45A4 SLCO1B7 SLC6A1 SLC7A1 SLC7A3 SLC4A10 NIPA2 SLC45A1 ATP2A1 ATP2A3 MFSD5 | 1.08e-03 | 1180 | 114 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.13e-03 | 9 | 114 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 1.13e-03 | 9 | 114 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.13e-03 | 9 | 114 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.40e-03 | 465 | 114 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | GRM7 RYR1 RYR2 KCNH4 SLC45A4 SLC6A1 SLC4A10 NIPA2 SLC45A1 ATP2A1 ATP2A3 | 1.47e-03 | 664 | 114 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.72e-03 | 11 | 114 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.75e-03 | 151 | 114 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 2.42e-03 | 13 | 114 | 2 | GO:0061459 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 HMCN1 PCDHGA12 PCDHGA8 | 3.56e-23 | 187 | 115 | 22 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | MAG PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PTPRD HMCN1 PCDHGA12 PCDHGA8 | 9.25e-21 | 313 | 115 | 24 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAG ERBB2 PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SIRPA CAV1 SLC7A1 PTPRD HMCN1 PCDHGA12 CCR7 PCDHGA8 AP3D1 | 1.25e-13 | 1077 | 115 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5P2 NPY2R OR5V1 FPR2 OR4E1 MC3R GPR37L1 OR1F12P OR5K4 GPR87 CAV1 GRM5 GRM7 ADCY5 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 BRS3 OR1Q1 OR52E1 OR52E5 OR6Y1 GPRC5D CCR7 OR10G8 OR6C6 GPR132 | 8.45e-11 | 1395 | 115 | 30 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 TLR6 RYR2 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 7.08e-10 | 524 | 115 | 18 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5P2 DMXL2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 6.67e-09 | 465 | 115 | 16 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5P2 DMXL2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 9.79e-09 | 547 | 115 | 17 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 1.21e-08 | 485 | 115 | 16 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 1.82e-08 | 432 | 115 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 TLR6 RYR2 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 9.98e-08 | 722 | 115 | 18 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 1.49e-07 | 582 | 115 | 16 | GO:0050906 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 5.20e-07 | 86 | 115 | 7 | GO:0007193 | |
| GeneOntologyBiologicalProcess | sensory perception | OR5P2 DMXL2 OR5V1 OR4E1 OR1F12P OR5K4 GRM7 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 HMCN1 OR1Q1 OR52E1 SLC4A10 OR52E5 OR6Y1 OR10G8 OR6C6 | 1.82e-06 | 1072 | 115 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 1.06e-05 | 25 | 115 | 4 | GO:0003214 | |
| GeneOntologyBiologicalProcess | lysine transport | 9.21e-05 | 3 | 115 | 2 | GO:0015819 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.27e-04 | 87 | 115 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.34e-04 | 88 | 115 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | cellular response to amyloid-beta | 1.60e-04 | 49 | 115 | 4 | GO:1904646 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle formation | 1.84e-04 | 4 | 115 | 2 | GO:0003218 | |
| GeneOntologyBiologicalProcess | oligosaccharide transport | 1.84e-04 | 4 | 115 | 2 | GO:0015772 | |
| GeneOntologyBiologicalProcess | sucrose transport | 1.84e-04 | 4 | 115 | 2 | GO:0015770 | |
| GeneOntologyBiologicalProcess | disaccharide transport | 1.84e-04 | 4 | 115 | 2 | GO:0015766 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.03e-04 | 286 | 115 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 3.75e-04 | 61 | 115 | 4 | GO:1904645 | |
| GeneOntologyBiologicalProcess | L-ornithine transmembrane transport | 4.56e-04 | 6 | 115 | 2 | GO:1903352 | |
| GeneOntologyBiologicalProcess | positive regulation of ATPase-coupled calcium transmembrane transporter activity | 4.56e-04 | 6 | 115 | 2 | GO:1901896 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 5.55e-04 | 29 | 115 | 3 | GO:1903779 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.09e-04 | 45 | 115 | 4 | GO:0033017 | |
| MousePheno | abnormal behavioral response to xenobiotic | 9.30e-06 | 309 | 63 | 9 | MP:0009745 | |
| MousePheno | abnormal xenobiotic induced morbidity/mortality | 1.13e-05 | 171 | 63 | 7 | MP:0009765 | |
| MousePheno | increased susceptibility to induced morbidity/mortality | 2.29e-05 | 346 | 63 | 9 | MP:0009763 | |
| MousePheno | increased susceptibility to xenobiotic induced morbidity/mortality | 2.89e-05 | 133 | 63 | 6 | MP:0009766 | |
| MousePheno | abnormal physiological response to xenobiotic | ABCC1 NPY2R TNFSF10 FPR2 CAV1 GRM7 RYR1 RYR2 OPRD1 SLCO1B7 CCR7 XPO7 | 3.33e-05 | 662 | 63 | 12 | MP:0008872 |
| MousePheno | abnormal susceptibility to induced morbidity/mortality | 4.41e-05 | 471 | 63 | 10 | MP:0020148 | |
| MousePheno | abnormal seizure response to pharmacological agent | 5.06e-05 | 147 | 63 | 6 | MP:0000950 | |
| MousePheno | decreased sperm progressive motility | 8.57e-05 | 100 | 63 | 5 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 8.99e-05 | 101 | 63 | 5 | MP:0020450 | |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 1.80e-04 | 117 | 63 | 5 | MP:0002906 | |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 1.87e-04 | 118 | 63 | 5 | MP:0012349 | |
| MousePheno | seizures | 2.01e-04 | 360 | 63 | 8 | MP:0002064 | |
| MousePheno | increased circulating glycerol level | 2.36e-04 | 27 | 63 | 3 | MP:0003443 | |
| MousePheno | abnormal seizure response to inducing agent | 2.82e-04 | 201 | 63 | 6 | MP:0009357 | |
| MousePheno | abnormal latent inhibition of conditioning behavior | 2.96e-04 | 6 | 63 | 2 | MP:0006299 | |
| MousePheno | decreased response to leptin | 2.96e-04 | 6 | 63 | 2 | MP:0014441 | |
| MousePheno | increased glycerol level | 3.94e-04 | 32 | 63 | 3 | MP:0003441 | |
| Domain | Cadherin_tail | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 3.54e-38 | 37 | 112 | 21 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 3.54e-38 | 37 | 112 | 21 | IPR031904 |
| Domain | Cadherin_2 | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.47e-31 | 65 | 112 | 21 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.47e-31 | 65 | 112 | 21 | IPR013164 |
| Domain | Cadherin_CS | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 2.99e-26 | 109 | 112 | 21 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 6.77e-26 | 113 | 112 | 21 | PS00232 |
| Domain | Cadherin | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 6.77e-26 | 113 | 112 | 21 | PF00028 |
| Domain | CADHERIN_2 | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 8.26e-26 | 114 | 112 | 21 | PS50268 |
| Domain | - | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 8.26e-26 | 114 | 112 | 21 | 2.60.40.60 |
| Domain | CA | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.01e-25 | 115 | 112 | 21 | SM00112 |
| Domain | Cadherin-like | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.22e-25 | 116 | 112 | 21 | IPR015919 |
| Domain | Cadherin | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.80e-25 | 118 | 112 | 21 | IPR002126 |
| Domain | Cadherin_C | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA7 PCDHGA12 PCDHGA8 | 5.00e-14 | 42 | 112 | 10 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA7 PCDHGA12 PCDHGA8 | 5.00e-14 | 42 | 112 | 10 | PF16492 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5P2 NPY2R OR5V1 FPR2 MC3R GPR37L1 OR1F12P OR5K4 GPR87 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 BRS3 OR1Q1 OR52E5 OR6Y1 CCR7 OR10G8 OR6C6 GPR132 | 1.70e-11 | 691 | 112 | 23 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5P2 NPY2R OR5V1 FPR2 MC3R GPR37L1 OR1F12P OR5K4 GPR87 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 BRS3 OR1Q1 OR52E5 OR6Y1 CCR7 OR10G8 OR6C6 GPR132 | 1.75e-11 | 692 | 112 | 23 | IPR000276 |
| Domain | 7tm_1 | OR5P2 NPY2R OR5V1 FPR2 MC3R GPR37L1 OR1F12P OR5K4 GPR87 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 BRS3 OR1Q1 OR52E5 OR6Y1 CCR7 OR10G8 OR6C6 GPR132 | 7.92e-11 | 677 | 112 | 22 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5P2 NPY2R OR5V1 FPR2 MC3R GPR37L1 OR1F12P OR5K4 GPR87 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 BRS3 OR1Q1 OR52E5 OR6Y1 CCR7 OR10G8 OR6C6 GPR132 | 9.91e-11 | 685 | 112 | 22 | PS00237 |
| Domain | GPCR_Rhodpsn_7TM | OR5P2 NPY2R OR5V1 FPR2 MC3R GPR37L1 OR5K4 GPR87 OPRD1 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 BRS3 OR1Q1 OR6Y1 CCR7 OR10G8 OR6C6 GPR132 | 4.37e-10 | 670 | 112 | 21 | IPR017452 |
| Domain | Olfact_rcpt | OR5P2 OR5V1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E5 OR6Y1 OR10G8 OR6C6 | 6.72e-07 | 393 | 112 | 13 | IPR000725 |
| Domain | Cyclin_Y | 3.56e-05 | 2 | 112 | 2 | IPR012399 | |
| Domain | Ryanrecept_TM4-6 | 1.07e-04 | 3 | 112 | 2 | IPR009460 | |
| Domain | RyR | 1.07e-04 | 3 | 112 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 1.07e-04 | 3 | 112 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 1.07e-04 | 3 | 112 | 2 | PF06459 | |
| Domain | P-type_ATPase_IIA | 1.07e-04 | 3 | 112 | 2 | IPR005782 | |
| Domain | Ryan_recept | 1.07e-04 | 3 | 112 | 2 | IPR013333 | |
| Domain | Cat_AA_permease | 1.07e-04 | 3 | 112 | 2 | IPR004755 | |
| Domain | GPCR_3 | 2.58e-04 | 21 | 112 | 3 | IPR000337 | |
| Domain | 7tm_3 | 2.97e-04 | 22 | 112 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 2.97e-04 | 22 | 112 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 2.97e-04 | 22 | 112 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 2.97e-04 | 22 | 112 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 2.97e-04 | 22 | 112 | 3 | PS50259 | |
| Domain | GPCR_3_C | 2.97e-04 | 22 | 112 | 3 | IPR017978 | |
| Domain | CAT3 | 3.52e-04 | 5 | 112 | 2 | IPR015606 | |
| Domain | AA_permease_C | 3.52e-04 | 5 | 112 | 2 | PF13906 | |
| Domain | CAT_C | 3.52e-04 | 5 | 112 | 2 | IPR029485 | |
| Domain | RIH_assoc | 5.26e-04 | 6 | 112 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 5.26e-04 | 6 | 112 | 2 | IPR013662 | |
| Domain | RIH_dom | 5.26e-04 | 6 | 112 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.26e-04 | 6 | 112 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.26e-04 | 6 | 112 | 2 | IPR015925 | |
| Domain | - | 5.26e-04 | 6 | 112 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.26e-04 | 6 | 112 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 5.26e-04 | 6 | 112 | 2 | PF08709 | |
| Domain | - | 9.17e-04 | 32 | 112 | 3 | 3.40.1110.10 | |
| Domain | - | 9.17e-04 | 32 | 112 | 3 | 2.70.150.10 | |
| Domain | GPCR_3_mtglu_rcpt | 9.75e-04 | 8 | 112 | 2 | IPR000162 | |
| Domain | ATPase_P-typ_cyto_domN | 1.19e-03 | 35 | 112 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 1.30e-03 | 36 | 112 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.30e-03 | 36 | 112 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.30e-03 | 36 | 112 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.41e-03 | 37 | 112 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.41e-03 | 37 | 112 | 3 | PF00122 | |
| Domain | WD_REPEATS_1 | 1.44e-03 | 278 | 112 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.47e-03 | 279 | 112 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.47e-03 | 279 | 112 | 7 | PS50294 | |
| Domain | MIR | 1.55e-03 | 10 | 112 | 2 | PS50919 | |
| Domain | MIR | 1.55e-03 | 10 | 112 | 2 | PF02815 | |
| Domain | MIR | 1.55e-03 | 10 | 112 | 2 | SM00472 | |
| Domain | MIR_motif | 1.55e-03 | 10 | 112 | 2 | IPR016093 | |
| Domain | Hydrolase_3 | 1.55e-03 | 10 | 112 | 2 | PF08282 | |
| Domain | NCD3G | 2.66e-03 | 13 | 112 | 2 | PF07562 | |
| Domain | AA_permease_2 | 2.66e-03 | 13 | 112 | 2 | PF13520 | |
| Domain | GPCR_3_9-Cys_dom | 2.66e-03 | 13 | 112 | 2 | IPR011500 | |
| Domain | AA/rel_permease1 | 2.66e-03 | 13 | 112 | 2 | IPR002293 | |
| Domain | GPCR_3_CS | 3.09e-03 | 14 | 112 | 2 | IPR017979 | |
| Domain | - | 3.56e-03 | 15 | 112 | 2 | 3.30.70.960 | |
| Domain | - | 3.95e-03 | 333 | 112 | 7 | 2.130.10.10 | |
| Domain | - | 4.05e-03 | 16 | 112 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 4.05e-03 | 16 | 112 | 2 | IPR023298 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.08e-03 | 335 | 112 | 7 | IPR015943 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.57e-03 | 17 | 112 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.57e-03 | 17 | 112 | 2 | PF00689 | |
| Domain | 7TM_GPCR_Srsx | 4.63e-03 | 112 | 112 | 4 | SM01381 | |
| Domain | Cation_ATPase_N | 5.12e-03 | 18 | 112 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 5.12e-03 | 18 | 112 | 2 | SM00831 | |
| Domain | WD40 | 5.56e-03 | 268 | 112 | 6 | SM00320 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.70e-03 | 19 | 112 | 2 | IPR004014 | |
| Domain | WD40_repeat | 5.97e-03 | 272 | 112 | 6 | IPR001680 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 9.57e-10 | 417 | 68 | 15 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 TAS2R8 OR1Q1 OR52E1 OR52E5 OR6Y1 OR10G8 OR6C6 | 4.02e-08 | 636 | 68 | 16 | M41834 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPY2R OR5V1 FPR2 MC3R GPR37L1 GPR87 OPRD1 OR2C1 BRS3 OR1Q1 CCR7 | 4.12e-08 | 260 | 68 | 11 | M39397 |
| Pathway | WP_GPCRS_PEPTIDE | 1.04e-06 | 70 | 68 | 6 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.56e-06 | 75 | 68 | 6 | M39696 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.97e-06 | 186 | 68 | 8 | MM15994 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | NPY2R FPR2 MC3R GPR37L1 GRM5 GRM7 OPRD1 TAS2R8 BRS3 CCR7 GPR132 | 1.20e-05 | 463 | 68 | 11 | M507 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR5P2 OR5V1 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR6Y1 OR10G8 OR6C6 | 1.59e-05 | 389 | 68 | 10 | M14091 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 3.75e-05 | 430 | 68 | 10 | MM15160 | |
| Pathway | WP_GPCRS_NONODORANT | 4.02e-05 | 266 | 68 | 8 | MM15843 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 4.41e-05 | 197 | 68 | 7 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 4.41e-05 | 197 | 68 | 7 | MM14970 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 4.69e-05 | 15 | 68 | 3 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 4.69e-05 | 15 | 68 | 3 | MM15845 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 6.94e-05 | 46 | 68 | 4 | M48105 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ATP9B RYR1 RYR2 SLCO1B7 SLC6A1 SLC7A1 SLC7A3 SLC4A10 NIPA2 ATP2A1 ATP2A3 | 8.85e-05 | 681 | 68 | 12 | MM14985 |
| Pathway | WP_GPCRS_ODORANT | 1.07e-04 | 157 | 68 | 6 | MM15872 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPY2R FPR2 MC3R GPR37L1 GRM5 GRM7 ADCY5 OPRD1 TAS2R8 BRS3 CCR7 GPR132 | 1.18e-04 | 702 | 68 | 12 | M746 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.28e-04 | 314 | 68 | 8 | M600 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.31e-04 | 54 | 68 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.31e-04 | 54 | 68 | 4 | MM15202 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.80e-04 | 330 | 68 | 8 | M18334 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC1 ATP9B ADCY5 RYR1 RYR2 SLC6A1 SLC7A1 SLC7A3 SLC4A10 NIPA2 ATP2A1 ATP2A3 | 1.84e-04 | 736 | 68 | 12 | M27287 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.92e-04 | 333 | 68 | 8 | MM14963 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.13e-04 | 178 | 68 | 6 | M2890 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPY2R FPR2 MC3R GPR37L1 GRM5 GRM7 ADCY5 OPRD1 BRS3 CCR7 GPR132 | 2.43e-04 | 646 | 68 | 11 | MM14962 |
| Pathway | BIOCARTA_NO1_PATHWAY | 3.23e-04 | 28 | 68 | 3 | M4383 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 3.27e-04 | 272 | 68 | 7 | M13380 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.57e-04 | 70 | 68 | 4 | MM14984 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.71e-04 | 289 | 68 | 7 | MM15057 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA | 6.30e-04 | 8 | 68 | 2 | M47955 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 8.66e-04 | 39 | 68 | 3 | M793 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.23e-03 | 11 | 68 | 2 | M47958 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.32e-03 | 45 | 68 | 3 | MM15671 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.47e-03 | 12 | 68 | 2 | M27326 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.53e-03 | 103 | 68 | 4 | MM15196 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.58e-03 | 176 | 68 | 5 | MM15718 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.73e-03 | 13 | 68 | 2 | M39589 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.88e-03 | 183 | 68 | 5 | M997 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 2.01e-03 | 14 | 68 | 2 | MM15052 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.35e-03 | 55 | 68 | 3 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.61e-03 | 57 | 68 | 3 | MM15643 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 | 8.33e-39 | 28 | 116 | 18 | 15347688 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 2.35e-36 | 68 | 116 | 21 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 9.58e-36 | 72 | 116 | 21 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.87e-35 | 74 | 116 | 21 | 10817752 |
| Pubmed | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 4.89e-35 | 77 | 116 | 21 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.23e-34 | 80 | 116 | 21 | 10716726 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 | 1.82e-31 | 57 | 116 | 18 | 32633719 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.29e-31 | 15 | 116 | 13 | 15640798 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.42e-30 | 17 | 116 | 13 | 29911975 | |
| Pubmed | PCDHA9 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.78e-29 | 24 | 116 | 14 | 24698270 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.66e-29 | 18 | 116 | 13 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.66e-29 | 18 | 116 | 13 | 10662547 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHGA7 PCDHGA6 PCDHGA3 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.68e-27 | 58 | 116 | 16 | 30377227 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 | 1.26e-24 | 11 | 116 | 10 | 9655502 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.36e-19 | 75 | 116 | 13 | 15372022 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.14e-18 | 119 | 116 | 14 | 28625976 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 5.86e-18 | 12 | 116 | 8 | 10612399 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRM7 WDR49 | 1.42e-16 | 193 | 116 | 15 | 22589738 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E5 OR6Y1 OR10G8 OR6C6 | 9.20e-12 | 340 | 116 | 14 | 11875048 |
| Pubmed | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E5 OR6Y1 OR10G8 OR6C6 | 9.20e-12 | 340 | 116 | 14 | 11802173 | |
| Pubmed | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E5 OR6Y1 OR10G8 OR6C6 | 1.03e-11 | 343 | 116 | 14 | 32295537 | |
| Pubmed | OR5P2 OR5V1 OR4E1 OR1F12P OR5K4 OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E5 OR6Y1 OR10G8 OR6C6 | 1.16e-11 | 346 | 116 | 14 | 14611657 | |
| Pubmed | PCDHA9 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA3 PCDHA2 PCDHA1 RYR1 ATP2A3 | 8.81e-11 | 329 | 116 | 13 | 17474147 | |
| Pubmed | 5.86e-10 | 5 | 116 | 4 | 34888534 | ||
| Pubmed | 1.11e-09 | 15 | 116 | 5 | 23515096 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 8.14e-09 | 8 | 116 | 4 | 19033399 | |
| Pubmed | 1.46e-08 | 9 | 116 | 4 | 12154121 | ||
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 3.50e-08 | 28 | 116 | 5 | 33523829 | |
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 3.62e-08 | 3 | 116 | 3 | 29477871 | |
| Pubmed | Functional significance of isoform diversification in the protocadherin gamma gene cluster. | 9.75e-08 | 34 | 116 | 5 | 22884324 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 9384575 | ||
| Pubmed | OR5P2 OR5V1 OR4E1 OR1F12P OR10G7 OR10G4 OR52E2 OR2C1 OR1Q1 OR52E5 OR6Y1 OR10G8 | 2.82e-07 | 541 | 116 | 12 | 14983052 | |
| Pubmed | 3.70e-07 | 44 | 116 | 5 | 19029045 | ||
| Pubmed | COPA PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 RYR2 OR10G7 OR10G4 PCDHGA12 ASPM OR10G8 TMPRSS7 ATP2A1 ATP2A3 PCDHGA8 AP3D1 | 1.40e-06 | 1442 | 116 | 18 | 35575683 | |
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 1.64e-06 | 59 | 116 | 5 | 23754746 | |
| Pubmed | 2.00e-06 | 8 | 116 | 3 | 11784029 | ||
| Pubmed | A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. | 2.99e-06 | 9 | 116 | 3 | 25640239 | |
| Pubmed | 4.26e-06 | 10 | 116 | 3 | 18434328 | ||
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 4.26e-06 | 10 | 116 | 3 | 24207026 | |
| Pubmed | 7.78e-06 | 12 | 116 | 3 | 24695638 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 7.94e-06 | 38 | 116 | 4 | 30786075 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32245295 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 20550696 | ||
| Pubmed | Erb-B2 homodimerization inhibits MUC1 transcription in cultured human mammary epithelial cells. | 1.10e-05 | 2 | 116 | 2 | 12798775 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17259277 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17974963 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.10e-05 | 2 | 116 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.10e-05 | 2 | 116 | 2 | 26009179 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32899693 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 27974697 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26172389 | ||
| Pubmed | PCDHA9 as a candidate gene for amyotrophic lateral sclerosis. | 1.10e-05 | 2 | 116 | 2 | 38467605 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30510281 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.10e-05 | 2 | 116 | 2 | 15033925 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23397229 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 9614060 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 23635475 | ||
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 1.10e-05 | 2 | 116 | 2 | 14697259 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30542613 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 1.10e-05 | 2 | 116 | 2 | 11673493 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11673462 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26838233 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25444743 | ||
| Pubmed | Caveolin-1 is involved in radiation-induced ERBB2 nuclear transport in breast cancer cells. | 1.10e-05 | 2 | 116 | 2 | 23271292 | |
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 1.10e-05 | 2 | 116 | 2 | 25370123 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26768616 | ||
| Pubmed | Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. | 1.10e-05 | 2 | 116 | 2 | 11591158 | |
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 1.10e-05 | 2 | 116 | 2 | 18618700 | |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.28e-05 | 14 | 116 | 3 | 11793228 | |
| Pubmed | 2.80e-05 | 105 | 116 | 5 | 30280653 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18403125 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31910438 | ||
| Pubmed | Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. | 3.30e-05 | 3 | 116 | 2 | 17852076 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 7876312 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22184064 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24123915 | ||
| Pubmed | Two novel CNRs from the CNR gene cluster have molecular features distinct from those of CNR1 to 8. | 3.30e-05 | 3 | 116 | 2 | 11401448 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 26892612 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23278119 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 20361287 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 15972723 | ||
| Pubmed | CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse. | 3.30e-05 | 3 | 116 | 2 | 26305884 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 29569026 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 3.30e-05 | 3 | 116 | 2 | 10788707 | |
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 3.30e-05 | 3 | 116 | 2 | 27161523 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 3.30e-05 | 3 | 116 | 2 | 7621815 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 24445321 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 3.30e-05 | 3 | 116 | 2 | 10473538 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31015522 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 21917590 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 3.30e-05 | 3 | 116 | 2 | 9204703 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 21881589 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 26667143 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 16024054 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 3.30e-05 | 3 | 116 | 2 | 12213830 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 22870827 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9334265 | ||
| Interaction | PCDHA10 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 | 6.98e-23 | 22 | 100 | 12 | int:PCDHA10 |
| Interaction | PCDHA9 interactions | PCDHA9 PCDHGA9 PCDHGA6 PCDHA11 PCDHA10 PCDHA7 PCDHA4 PCDHA3 PCDHGA12 | 3.22e-14 | 32 | 100 | 9 | int:PCDHA9 |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.39e-13 | 55 | 100 | 10 | int:PCDHA8 |
| Interaction | PCDHA7 interactions | 2.00e-13 | 14 | 100 | 7 | int:PCDHA7 | |
| Interaction | PCDHA11 interactions | 2.87e-12 | 19 | 100 | 7 | int:PCDHA11 | |
| Interaction | FLT3 interactions | ERBB2 PCDHA9 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 AP3D1 | 4.13e-12 | 318 | 100 | 16 | int:FLT3 |
| Interaction | PCDHA3 interactions | 4.51e-12 | 34 | 100 | 8 | int:PCDHA3 | |
| Interaction | PCDHGA4 interactions | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA12 PCDHGA8 | 4.51e-12 | 34 | 100 | 8 | int:PCDHGA4 |
| Interaction | PCDHGA10 interactions | 3.30e-10 | 19 | 100 | 6 | int:PCDHGA10 | |
| Interaction | PCDHA1 interactions | 3.37e-10 | 9 | 100 | 5 | int:PCDHA1 | |
| Interaction | PCDHA4 interactions | 5.72e-10 | 60 | 100 | 8 | int:PCDHA4 | |
| Interaction | PCDHA12 interactions | 2.73e-09 | 46 | 100 | 7 | int:PCDHA12 | |
| Interaction | PCDHGA9 interactions | 1.27e-08 | 33 | 100 | 6 | int:PCDHGA9 | |
| Interaction | PCDHA6 interactions | 7.05e-08 | 9 | 100 | 4 | int:PCDHA6 | |
| Interaction | PCDHGA6 interactions | 1.07e-07 | 24 | 100 | 5 | int:PCDHGA6 | |
| Interaction | PCDHGA12 interactions | 1.17e-07 | 10 | 100 | 4 | int:PCDHGA12 | |
| Interaction | MLYCD interactions | 3.51e-07 | 30 | 100 | 5 | int:MLYCD | |
| Interaction | PCDHA2 interactions | 5.50e-07 | 14 | 100 | 4 | int:PCDHA2 | |
| Interaction | LONP2 interactions | 6.30e-07 | 62 | 100 | 6 | int:LONP2 | |
| Interaction | PCDHGA5 interactions | 6.93e-07 | 63 | 100 | 6 | int:PCDHGA5 | |
| Interaction | PCDHGA8 interactions | 1.18e-06 | 5 | 100 | 3 | int:PCDHGA8 | |
| Interaction | PCDHGB2 interactions | 2.53e-06 | 44 | 100 | 5 | int:PCDHGB2 | |
| Interaction | PCDHA13 interactions | 4.09e-06 | 7 | 100 | 3 | int:PCDHA13 | |
| Interaction | TCEAL2 interactions | 5.62e-06 | 24 | 100 | 4 | int:TCEAL2 | |
| Interaction | LTBP1 interactions | 6.48e-06 | 92 | 100 | 6 | int:LTBP1 | |
| Interaction | PCDHGA7 interactions | 6.66e-06 | 25 | 100 | 4 | int:PCDHGA7 | |
| Interaction | TMEM223 interactions | 1.01e-05 | 58 | 100 | 5 | int:TMEM223 | |
| Interaction | ABCB9 interactions | 2.36e-05 | 34 | 100 | 4 | int:ABCB9 | |
| Interaction | H2BC5 interactions | PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHGA12 ASPM PCDHGA8 | 4.00e-05 | 331 | 100 | 9 | int:H2BC5 |
| Interaction | HCRTR2 interactions | 4.11e-05 | 39 | 100 | 4 | int:HCRTR2 | |
| Interaction | FPR2 interactions | 6.50e-05 | 138 | 100 | 6 | int:FPR2 | |
| Interaction | EPHB4 interactions | 8.88e-05 | 146 | 100 | 6 | int:EPHB4 | |
| Interaction | EXOG interactions | 1.29e-04 | 52 | 100 | 4 | int:EXOG | |
| Interaction | PCDHA5 interactions | 1.45e-04 | 4 | 100 | 2 | int:PCDHA5 | |
| Interaction | ATP2A3 interactions | 1.58e-04 | 232 | 100 | 7 | int:ATP2A3 | |
| Interaction | ATL2 interactions | 1.70e-04 | 104 | 100 | 5 | int:ATL2 | |
| Interaction | ADGRB3 interactions | 1.95e-04 | 23 | 100 | 3 | int:ADGRB3 | |
| Interaction | C2CD2L interactions | 2.40e-04 | 112 | 100 | 5 | int:C2CD2L | |
| Interaction | SLC10A7 interactions | 2.52e-04 | 25 | 100 | 3 | int:SLC10A7 | |
| Interaction | RELN interactions | 3.18e-04 | 27 | 100 | 3 | int:RELN | |
| Interaction | YIPF3 interactions | 3.31e-04 | 186 | 100 | 6 | int:YIPF3 | |
| Interaction | SIGLEC1 interactions | 3.61e-04 | 6 | 100 | 2 | int:SIGLEC1 | |
| Interaction | LPAR6 interactions | 3.64e-04 | 68 | 100 | 4 | int:LPAR6 | |
| Interaction | CYB5R1 interactions | 4.29e-04 | 127 | 100 | 5 | int:CYB5R1 | |
| Interaction | PLN interactions | 4.53e-04 | 72 | 100 | 4 | int:PLN | |
| Interaction | GPR152 interactions | 4.62e-04 | 198 | 100 | 6 | int:GPR152 | |
| Cytoband | 5q31 | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 1.82e-33 | 115 | 116 | 21 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 2.07e-24 | 298 | 116 | 21 | chr5q31 |
| Cytoband | 11q24.2 | 5.59e-04 | 63 | 116 | 3 | 11q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 1.45e-03 | 191 | 116 | 4 | chr11q24 | |
| Cytoband | 11p15.4 | 1.71e-03 | 200 | 116 | 4 | 11p15.4 | |
| Cytoband | 18q23 | 2.46e-03 | 29 | 116 | 2 | 18q23 | |
| Cytoband | Xq22.3 | 3.18e-03 | 33 | 116 | 2 | Xq22.3 | |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA12 PCDHGA8 | 2.65e-33 | 64 | 93 | 21 | 20 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 7.83e-05 | 3 | 93 | 2 | 287 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 7.18e-04 | 8 | 93 | 2 | 281 | |
| GeneFamily | ATPases Ca2+ transporting | 9.20e-04 | 9 | 93 | 2 | 1209 | |
| GeneFamily | Olfactory receptors, family 52 | 2.05e-03 | 49 | 93 | 3 | 165 | |
| GeneFamily | WD repeat domain containing | 2.33e-03 | 262 | 93 | 6 | 362 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 4.21e-03 | 394 | 93 | 7 | 471 | |
| GeneFamily | Solute carriers | 4.27e-03 | 395 | 93 | 7 | 752 | |
| GeneFamily | Olfactory receptors, family 10 | 4.77e-03 | 66 | 93 | 3 | 157 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 7.59e-03 | 78 | 93 | 3 | 262 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 ACRBP PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.70e-12 | 261 | 112 | 14 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 ACRBP PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.15e-11 | 238 | 112 | 13 | M2020 |
| CoexpressionAtlas | cerebral cortex | MAG NPY2R PCDHGA9 PCDHGA7 PCDHGA3 GPR37L1 PCDHA11 PCDHA10 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA1 GRM5 GRM7 KCNH4 OPRD1 SLC6A1 PTPRD GPR137C SLC4A10 SLC45A1 | 1.64e-07 | 1428 | 93 | 22 | cerebral cortex |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA3 PCDHA1 PTPRD CCR7 WDR86 HSD11B1 | 1.35e-11 | 159 | 116 | 10 | b4bc888e978b1b577721b891b0af6ba9a1607044 |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-08 | 188 | 116 | 8 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.78e-07 | 190 | 116 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.91e-06 | 85 | 116 | 5 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.91e-06 | 85 | 116 | 5 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.40e-06 | 163 | 116 | 6 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.06e-06 | 167 | 116 | 6 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-06 | 177 | 116 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-06 | 177 | 116 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.29e-06 | 178 | 116 | 6 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-06 | 178 | 116 | 6 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.37e-06 | 186 | 116 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.66e-06 | 187 | 116 | 6 | 6c43669e19b5b54d72d1f5d876184fee53c05f0b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-05 | 196 | 116 | 6 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-05 | 198 | 116 | 6 | 243109377d62d20c69e9d1fedc252156e90cda1e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 200 | 116 | 6 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-05 | 200 | 116 | 6 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 1.84e-05 | 124 | 116 | 5 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.49e-05 | 132 | 116 | 5 | 6480feb3e4e898d610615ce14f598f419c623e07 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 71 | 116 | 4 | 5d63a582229520b2a037f3c27f772e34cdee092b | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.44e-05 | 149 | 116 | 5 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.44e-05 | 149 | 116 | 5 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.59e-05 | 150 | 116 | 5 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.16e-05 | 78 | 116 | 4 | 1ddbb2247450a8b1c159f524dee15bf688748955 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Ctps_(Ctps)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.16e-05 | 78 | 116 | 4 | 2b0973122052bb26153f066e7b87c26f8a319698 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 158 | 116 | 5 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.05e-05 | 159 | 116 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.59e-05 | 83 | 116 | 4 | 3f24edf3775c20bda6f8e3fa3c54844bca731383 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.59e-05 | 83 | 116 | 4 | 1798900df5dfbcd09566041b21d9d84be65aee08 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.59e-05 | 83 | 116 | 4 | 3086a83608403b780ca9d86c474d2f19211e76ee | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 162 | 116 | 5 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-05 | 163 | 116 | 5 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-05 | 163 | 116 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.85e-05 | 168 | 116 | 5 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| Drug | Azacitidine | PCDHA9 TNFSF10 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.81e-08 | 415 | 107 | 13 | ctd:D001374 |
| Drug | myo-inositol | ERBB2 NPY2R ACACA FPR2 GPR87 GRM5 GRM7 ADCY5 RYR1 RYR2 OPRD1 CHPT1 BRS3 GPRC5D ATP2A1 ATP2A3 GPR132 | 2.33e-07 | 811 | 107 | 17 | CID000000892 |
| Drug | AC1L1KS5 | 5.08e-07 | 334 | 107 | 11 | CID000005631 | |
| Drug | CID9959010 | 1.06e-06 | 39 | 107 | 5 | CID009959010 | |
| Drug | AC1L380G | 1.69e-06 | 19 | 107 | 4 | CID000084698 | |
| Drug | Fura-2AM | 1.97e-06 | 79 | 107 | 6 | CID000105091 | |
| Drug | Dantrolene-13C3 | 5.63e-06 | 145 | 107 | 7 | CID000002951 | |
| Drug | indo-1 | 7.35e-06 | 99 | 107 | 6 | CID000105060 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.46e-05 | 233 | 107 | 8 | CID000005114 | |
| Drug | R 478 | 1.62e-05 | 11 | 107 | 3 | CID000084223 | |
| Drug | persulfate | 1.62e-05 | 11 | 107 | 3 | CID000024413 | |
| Drug | TMB-8 | 1.99e-05 | 176 | 107 | 7 | CID000005494 | |
| Drug | fluo-3 | 2.43e-05 | 122 | 107 | 6 | CID000104978 | |
| Drug | mag-fura-2 | 2.70e-05 | 37 | 107 | 4 | CID000123839 | |
| Drug | 4-chloro-m-cresol | 2.70e-05 | 37 | 107 | 4 | CID000001732 | |
| Drug | baclofen | 3.37e-05 | 191 | 107 | 7 | CID000002284 | |
| Drug | montmorillonite | 3.70e-05 | 40 | 107 | 4 | CID000517273 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.97e-05 | 196 | 107 | 7 | 990_UP | |
| Drug | XeC compound | 4.80e-05 | 84 | 107 | 5 | CID000005701 | |
| Drug | nimodipine | 6.41e-05 | 145 | 107 | 6 | CID000004497 | |
| Drug | fentanyl isothiocyanate | 6.54e-05 | 17 | 107 | 3 | CID000084008 | |
| Drug | cis-diammineplatinum(II | 6.54e-05 | 3 | 107 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.54e-05 | 3 | 107 | 2 | CID002750949 | |
| Drug | 8N3-cADPR | 6.54e-05 | 3 | 107 | 2 | CID000127713 | |
| Drug | aminodantrolene | 6.54e-05 | 3 | 107 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 6.54e-05 | 3 | 107 | 2 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.54e-05 | 3 | 107 | 2 | CID005748312 | |
| Drug | KB-R7943 | 7.04e-05 | 47 | 107 | 4 | CID004534086 | |
| Drug | 2-amino-4-phosphonobutyric acid | 7.04e-05 | 91 | 107 | 5 | CID000002207 | |
| Drug | AC1MMLID | 7.42e-05 | 92 | 107 | 5 | CID000013245 | |
| Drug | methylcoumarin | 7.82e-05 | 18 | 107 | 3 | CID000007092 | |
| Drug | NSC 234205 | 7.82e-05 | 18 | 107 | 3 | CID000010104 | |
| Drug | Zm 241385 | 8.30e-05 | 49 | 107 | 4 | CID000176407 | |
| Drug | nitrous oxide | 9.08e-05 | 96 | 107 | 5 | CID000000948 | |
| Drug | aminocyclopentane | 9.26e-05 | 19 | 107 | 3 | CID000002906 | |
| Drug | SK&F 82958 | 9.26e-05 | 19 | 107 | 3 | ctd:C071262 | |
| Drug | PCB74 | 1.30e-04 | 4 | 107 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 1.30e-04 | 4 | 107 | 2 | CID006444275 | |
| Drug | SC 38249 | 1.30e-04 | 4 | 107 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 1.30e-04 | 4 | 107 | 2 | CID000035682 | |
| Drug | dimethyl sulfide | 1.31e-04 | 55 | 107 | 4 | CID000001068 | |
| Drug | AC1L1UVI | 1.31e-04 | 55 | 107 | 4 | CID000061263 | |
| Drug | BAPTA | 1.48e-04 | 324 | 107 | 8 | CID000104751 | |
| Drug | phosphine oxide | 1.52e-04 | 107 | 107 | 5 | CID000166931 | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.34e-25 | 29 | 109 | 13 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.29e-18 | 87 | 109 | 13 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SLC45A4 | 1.19e-13 | 224 | 109 | 14 | EFO_0004833, EFO_0005090 |
| Disease | post-traumatic stress disorder symptom measurement | PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ADCY5 PTPRD | 5.32e-13 | 82 | 109 | 10 | EFO_0008535 |
| Disease | mental development measurement | 3.51e-12 | 25 | 109 | 7 | EFO_0008230 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 PTPRD PCDHGA12 PCDHGA8 | 5.63e-12 | 71 | 109 | 9 | EFO_0007878, EFO_0007979 |
| Disease | Sarcosine measurement | 2.12e-10 | 23 | 109 | 6 | EFO_0021668 | |
| Disease | Abnormality of refraction | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CAV1 ADCY5 SLC45A4 SLC6A1 | 4.65e-10 | 673 | 109 | 17 | HP_0000539 |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRM5 GRM7 | 2.82e-09 | 566 | 109 | 15 | EFO_0007660, EFO_0008354 |
| Disease | vital capacity | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRM7 RYR2 SLC6A1 CCNYL1 PTPRD HMCN1 MUC1 | 2.45e-08 | 1236 | 109 | 20 | EFO_0004312 |
| Disease | post-traumatic stress disorder | 8.83e-07 | 202 | 109 | 8 | EFO_0001358 | |
| Disease | pulse pressure measurement | PCDHA9 PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CAV1 ADCY5 KCNH4 PTPRD AP3D1 | 3.38e-06 | 1392 | 109 | 18 | EFO_0005763 |
| Disease | lymphocyte count | ABCC1 ACACA OR5V1 PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 GPR87 PCDHA6 CAV1 ADCY5 SLC45A4 PCDHGA12 CCR7 PCDHGA8 AP3D1 | 6.77e-06 | 1464 | 109 | 18 | EFO_0004587 |
| Disease | depressive symptom measurement | OR5V1 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 GRM5 TBC1D21 | 2.99e-05 | 426 | 109 | 9 | EFO_0007006 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Brody myopathy (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | phenylalanylphenylalanine measurement | 4.05e-05 | 3 | 109 | 2 | EFO_0021131 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | neutrophil count | PCDHA9 COPA PCDHA13 PCDHA12 PCDHA11 PCDHA10 PCDHA8 PCDHA7 PCDHA6 PCDHA5 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SLC45A4 AP3D1 | 4.80e-05 | 1382 | 109 | 16 | EFO_0004833 |
| Disease | Attention Deficit Disorder | 7.17e-05 | 22 | 109 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 7.17e-05 | 22 | 109 | 3 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 9.38e-05 | 24 | 109 | 3 | C1263846 | |
| Disease | Hypoplastic Left Heart Syndrome | 1.34e-04 | 5 | 109 | 2 | C0152101 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 2.01e-04 | 6 | 109 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | Epilepsy, Cryptogenic | 2.47e-04 | 82 | 109 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 2.47e-04 | 82 | 109 | 4 | C0751111 | |
| Disease | Aura | 2.47e-04 | 82 | 109 | 4 | C0236018 | |
| Disease | heart disease (implicated_via_orthology) | 3.76e-04 | 38 | 109 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | mean platelet volume | PCDHGA9 PCDHGA7 PCDHGA6 PCDHGA5 PCDHGA3 PCDHGA2 SIRPA OPRD1 SLC45A4 PCDHGA12 WDR49 PCDHGA8 | 3.94e-04 | 1020 | 109 | 12 | EFO_0004584 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 6.63e-04 | 46 | 109 | 3 | DOID:5426 (implicated_via_orthology) | |
| Disease | Epilepsy | 7.28e-04 | 109 | 109 | 4 | C0014544 | |
| Disease | decanoylcarnitine measurement | 8.71e-04 | 12 | 109 | 2 | EFO_0021039 | |
| Disease | Drug habituation | 8.89e-04 | 115 | 109 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 8.89e-04 | 115 | 109 | 4 | C0236969 | |
| Disease | Drug abuse | 8.89e-04 | 115 | 109 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 8.89e-04 | 115 | 109 | 4 | C0013222 | |
| Disease | Drug Dependence | 8.89e-04 | 115 | 109 | 4 | C1510472 | |
| Disease | Substance Dependence | 8.89e-04 | 115 | 109 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 8.89e-04 | 115 | 109 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 8.89e-04 | 115 | 109 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 8.89e-04 | 115 | 109 | 4 | C4316881 | |
| Disease | Substance abuse problem | 9.18e-04 | 116 | 109 | 4 | C0740858 | |
| Disease | Carcinogenesis | 1.03e-03 | 13 | 109 | 2 | C0596263 | |
| Disease | Withdrawal Symptoms | 1.31e-03 | 58 | 109 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.31e-03 | 58 | 109 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.31e-03 | 58 | 109 | 3 | C0038587 | |
| Disease | language measurement | 1.57e-03 | 134 | 109 | 4 | EFO_0007797 | |
| Disease | Cocaine Dependence | 1.79e-03 | 139 | 109 | 4 | C0600427 | |
| Disease | Age-related macular degeneration | 1.99e-03 | 18 | 109 | 2 | cv:C0242383 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.15e-03 | 69 | 109 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | exercise test | 2.46e-03 | 20 | 109 | 2 | EFO_0004328 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.46e-03 | 20 | 109 | 2 | DOID:3328 (is_marker_for) | |
| Disease | osteoarthritis (biomarker_via_orthology) | 2.71e-03 | 21 | 109 | 2 | DOID:8398 (biomarker_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 3.23e-03 | 268 | 109 | 5 | C0001973 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 3.25e-03 | 23 | 109 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 3.25e-03 | 23 | 109 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 3.25e-03 | 23 | 109 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 3.25e-03 | 23 | 109 | 2 | C0014556 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.28e-03 | 80 | 109 | 3 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVSRLLGICLTSTVQ | 781 | P04626 | |
| ACVSKIYLNTLATVL | 421 | Q8NDM7 | |
| AVAAVLYVIVRCLNL | 21 | P08910 | |
| LVLCYSIVENTCIIT | 326 | Q8NEB7 | |
| LLLCISIDRYVAIVQ | 146 | P32248 | |
| YNEIITISLVTCRAI | 1811 | Q13085 | |
| AAVCTIIALSVVYSQ | 21 | P15144 | |
| AAQLTAECAIVTLVY | 181 | Q8ND76 | |
| NILLCEAVVAVYLSL | 2341 | Q8TDJ6 | |
| ACYALIAVVLAVQVV | 301 | O95622 | |
| YSVSRVNVSITLCVL | 201 | P28845 | |
| SFLIEIQCISRVYSI | 136 | Q03135 | |
| AAQLTAECAIVTLVY | 201 | Q8N7R7 | |
| LTAVRTQAVICIQSY | 2661 | Q8IZT6 | |
| IRYLISSNVGEVVCI | 761 | O14983 | |
| IRYLISSNVGEVVCI | 761 | Q93084 | |
| LYECVNTVIAVLISL | 276 | O14617 | |
| LYLVVAVATVSCVFL | 691 | Q9Y5G6 | |
| VTLVDVNVYLIIAIC | 691 | Q9Y5H5 | |
| VNVYLIIAICAVSSL | 696 | Q9Y5H5 | |
| LYLVVAVAAVSCVFL | 691 | Q9Y5H1 | |
| LYLVVAVAAVSCVFL | 691 | Q9Y5G8 | |
| LYLVVAVAAISCVFL | 691 | Q9Y5G5 | |
| LYLVVAVAAVSCVFL | 691 | O60330 | |
| LIEVQVVLILAYCSI | 46 | P49146 | |
| ATLVDVNVYLIIAIC | 691 | Q9Y5H9 | |
| VNVYLIIAICAVSSL | 696 | Q9Y5H9 | |
| AALVDVNVYLIIAIC | 691 | Q9UN73 | |
| VNVYLIIAICAVSSL | 696 | Q9UN73 | |
| TELVDVNVYLIIAIC | 691 | Q9UN72 | |
| VNVYLIIAICAVSSL | 696 | Q9UN72 | |
| AIVISYVQILCAVFL | 211 | Q8NGJ3 | |
| CNLVFDITVIALSYV | 206 | Q8NGJ4 | |
| VSIALAQYLITACLE | 296 | P57723 | |
| ALVDVNVYLIIAICV | 691 | Q9Y5I1 | |
| NVYLIIAICVVSSLL | 696 | Q9Y5I1 | |
| VLIVLSYVSIVCSIL | 211 | Q8NGN6 | |
| SVCILVSYILIVSAV | 211 | Q8NHA8 | |
| VLIVLSYVSIVCSIL | 211 | Q8NGN3 | |
| LYLVVAVAAVSCVFL | 691 | Q9Y5G7 | |
| AALVDVNVYLIIAIC | 691 | Q9Y5H6 | |
| VNVYLIIAICAVSSL | 696 | Q9Y5H6 | |
| VNVYLIVAICAVSSL | 696 | Q9Y5H8 | |
| IREVYLICNTTNLGV | 726 | P41594 | |
| VAFAILIAIVCYITQ | 521 | P20916 | |
| TRTVTTICYLNLALA | 56 | P25090 | |
| VSAITVVSCLPLYVL | 1116 | O43861 | |
| ACYNLVVVTISQDTL | 261 | Q8N3F9 | |
| VALAIVYLIALAVCQ | 1171 | P15941 | |
| CINLITSQEYAVKII | 101 | Q9HBH9 | |
| LYLVVAVAVVSCVFL | 691 | Q9Y5G4 | |
| TNILVYITICSVIGA | 176 | Q8N8Q9 | |
| LERYSQCSAVVLTLL | 351 | Q9UQ05 | |
| VLIVLSYVSIVCSIL | 211 | Q8NGN5 | |
| LSIIVISYCLIAQAV | 211 | O95371 | |
| ALVDVNVYLIIAICA | 691 | Q9Y5H7 | |
| NVYLIIAICAVSSLL | 696 | Q9Y5H7 | |
| AVTYVNSCLFVAVLV | 206 | Q9BY21 | |
| RAVLTCLIISAVDYN | 536 | Q96RW7 | |
| LALAIAITALYSAVC | 46 | P41143 | |
| LYCLIVAVTSLQCIT | 11 | B3GLJ2 | |
| AALVDVNVYLIIAIC | 691 | Q9Y5I3 | |
| VNVYLIIAICAVSSL | 696 | Q9Y5I3 | |
| AALVDVNVYLIIAIC | 691 | Q9Y5I0 | |
| VNVYLIIAICAVSSL | 696 | Q9Y5I0 | |
| LVDVNVYLIIAICAV | 691 | Q9Y5I2 | |
| VYLIIAICAVSSLLV | 696 | Q9Y5I2 | |
| LYLVVAVAAVSCVFL | 691 | Q9Y5H0 | |
| SIIVVTVCVIAVCYI | 201 | Q8WZ92 | |
| LSYICIISTILRIQS | 216 | Q9UGF6 | |
| AALVDVNVYLIIAIC | 691 | Q9UN74 | |
| VNVYLIIAICAVSSL | 696 | Q9UN74 | |
| LTTTVCLVAAALRYL | 96 | Q15884 | |
| VDLAISVAYCLQTVT | 201 | Q7Z4Q2 | |
| CSLLQIIIATEYVTL | 136 | Q9NZD1 | |
| QQLITICREYIVGLS | 1051 | P53621 | |
| NVCNIVVAYLSTELT | 376 | O60883 | |
| SICNLLAIAVDRYVT | 131 | P41968 | |
| ITDLQIICSLGYSIL | 751 | Q14831 | |
| TLSRNLYVVLSLCIT | 656 | Q9Y2W3 | |
| TINIIICTVDYLLRL | 3911 | P21817 | |
| LILEDVQVSCYRILT | 3121 | Q92736 | |
| IVYVCSSLLAVLLTA | 476 | Q8WY07 | |
| QVVLLNTSYSLVACA | 241 | Q66K64 | |
| QIAILYVCGLASTVL | 76 | Q6N075 | |
| ICILEISILTAQYTT | 11 | P02748 | |
| AALVDINVYLIIAIC | 691 | Q9UN75 | |
| INVYLIIAICAVSSL | 696 | Q9UN75 | |
| QVTLLDTVELATYCV | 1481 | P23468 | |
| LAFITASYACIILVV | 211 | Q15612 | |
| VLTVTGIDRYIAICN | 116 | Q8NH55 | |
| YTVLLFVTACLQTLV | 366 | P33527 | |
| SRIVLVVVYSAVCTL | 41 | Q9UNW8 | |
| AVCIISYLIGLSNIT | 426 | P30531 | |
| LISAACVVYAELIQK | 311 | Q8IYX1 | |
| LILCTVSVASYELTQ | 11 | P01718 | |
| TISVSQCEIFLGIIY | 936 | Q8IVG5 | |
| LTVGLLSQTYLECVQ | 146 | Q8TE76 | |
| NIYIVVGVVCTLLVA | 371 | P78324 | |
| CAVGLTSYSVLVIRI | 501 | G3V0H7 | |
| VIAIPLCVVVASYAA | 211 | Q8NGX8 | |
| LCVVVASYAAILATI | 216 | Q8NGX8 | |
| IQIFTIATVLISYLC | 206 | A6NMS3 | |
| VVTLVLVILSYTCII | 206 | A6NF89 | |
| ALCAIYITYAVIISV | 46 | P32247 | |
| LAVNVVTTLVLISYC | 71 | Q8WUD6 | |
| ILSCQVYISQILVAS | 666 | Q5BKX6 | |
| VCSITSVLSQQAYVL | 356 | A6NCW0 | |
| VSAIVLANLCVSYIM | 496 | Q8N4P2 | |
| VNVTVGSNVTLICIY | 31 | Q86XK7 | |
| CAVYVVNITQVIELL | 356 | Q9BVS5 | |
| QYCVVNILSVTSAIV | 56 | Q969K7 | |
| VCSITSVLSQQAYVL | 356 | A6NCW7 | |
| SVVCFVVLVVSYAVI | 211 | P0C645 | |
| LIDQTLCVSTYGIIT | 756 | Q7RTY8 | |
| TLLAYSLVAACVLVL | 416 | P30825 | |
| NVVYIYTVILAEICL | 356 | C9JQI7 | |
| IILVATDASSLVCYI | 606 | Q6U841 | |
| VTCVLYNSILKQVIS | 151 | Q8IV35 | |
| QTLELVLYTLCAVSA | 676 | Q6ZS81 | |
| VCSIISVLSQQAYVL | 356 | Q7RTZ2 | |
| QSYLVISLVLCVVLG | 1011 | Q9UBS9 | |
| LVLAVTVTSLCIYLD | 596 | Q9Y2C9 | |
| CILVVASNIYSAMLV | 831 | Q9H330 | |
| VSAIVLANLCVSYIM | 496 | Q86WT1 | |
| EYCIIGVTILSQLTN | 146 | Q9UIA9 | |
| YILTNLVIARICLIS | 46 | Q9NYW2 | |
| IFTVLLQSLCVAVTY | 21 | P50591 | |
| VASNTCNIILIYSVI | 356 | Q9H6R7 | |
| GSVICLELVNRLVYS | 236 | Q86TI4 | |
| TYVCLVLLVANILRI | 51 | Q8N2U9 | |
| ISCSIAYVALVTLLI | 51 | Q5W0B7 |